Key facts
- Unifarco’s last known valuation is $100.0M (Dec 2025).
- It has raised $20.0M; the latest was PE Growth/Expansion ($20.0M) in Dec 2025.
- Notable investors include Arca Fondi.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Unifarco
- ·The full record, as it builds
Funding rounds
No funding rounds for Unifarco are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Unifarco
Manufacturer of dermo cosmetic personal care products intended to serve pharmacies, retailers, and individual consumers seeking skin-care and wellness items. The company offers skincare creams and lotions, body and hair care products, natural cosmetic formulations, and dermo-cosmetic treatments, thereby enabling clients to access a range of personal care products developed with natural and scientifically validated ingredients.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Santa Giustina, Italy
- Founded
- 1982
- Employees
- 606
- Website
- unifarco.com/
- Ownership
- Privately Held (backing)
Unifarco doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Unifarco shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Unifarco in its N-PORT filings yet. We sweep new filings monthly.